iodonitrotetrazolium has been researched along with Granulomatous Disease, Chronic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campion, Y; Fieschi, F; Gaudin, P; Grunwald, D; Li, XJ; Morel, F; Paclet, MH; Stasia, MJ | 1 |
Cross, AR; Curnutte, JT; Yarchover, JL | 1 |
2 other study(ies) available for iodonitrotetrazolium and Granulomatous Disease, Chronic
Article | Year |
---|---|
Leu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly.
Topics: Amino Acid Sequence; Cell Line, Tumor; Chromosomes, Human, X; Cytochrome b Group; Enzyme Activation; Granulomatous Disease, Chronic; Humans; Leucine; Membrane Glycoproteins; Molecular Sequence Data; NADPH Oxidase 2; NADPH Oxidases; Neutrophils; Oxidoreductases; Phagosomes; Phosphoproteins; Protein Structure, Tertiary; Protein Transport; Recombinant Proteins; Sequence Homology, Amino Acid; Structure-Activity Relationship; Tetrazolium Salts | 2007 |
The superoxide-generating system of human neutrophils possesses a novel diaphorase activity. Evidence for distinct regulation of electron flow within NADPH oxidase by p67-phox and p47-phox.
Topics: Aerobiosis; Anaerobiosis; Biphenyl Compounds; Cell-Free System; Dihydrolipoamide Dehydrogenase; Dose-Response Relationship, Drug; Enzyme Activation; Granulomatous Disease, Chronic; Humans; Membranes; NADH, NADPH Oxidoreductases; NADPH Dehydrogenase; NADPH Oxidases; Neutrophils; Onium Compounds; Oxidation-Reduction; Phosphoproteins; Superoxides; Tetrazolium Salts | 1994 |